+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Angina Pectoris Drugs Market by Drug Class (Ace Inhibitors, Antiplatelet Agents, Beta Blockers), Dosage Form (Capsule, Injection, Patch), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Angina Pectoris Drugs Market by Drug Class (Ace Inhibitors, Antiplatelet Agents, Beta Blockers), Dosage Form (Capsule, Injection, Patch), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Angina Pectoris Drugs Market by Drug Class (Ace Inhibitors, Antiplatelet Agents, Beta Blockers), Dosage Form (Capsule, Injection, Patch), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715602
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The angina pectoris drugs market is evolving alongside clinical advancements and policy changes worldwide, demanding informed strategies from senior decision-makers. Therapeutic innovation, growing disease burden, and global supply chain shifts call for clear insight into segmentation, emerging modalities, and competitive positioning.

Market Snapshot: Angina Pectoris Drugs Market Size and Trends

The Angina Pectoris Drugs Market grew from USD 1.20 billion in 2024 to USD 1.27 billion in 2025. It is expected to continue growing at a CAGR of 5.46%, reaching USD 1.65 billion by 2030. Industry expansion reflects increased prevalence of underlying cardiovascular risk factors globally and accelerating adoption of diversified therapy classes in both established and emerging economies. Regulatory flexibility and the integration of digital health solutions are shaping new opportunities for market participants, while evolving payer models drive demand for evidence-based drug regimens.

Scope & Segmentation Analysis

  • Drug Classes: ACE inhibitors (notably Enalapril, Lisinopril), antiplatelet agents (Aspirin, P2Y12 inhibitors), beta blockers (selective and nonselective subtypes), calcium channel blockers (dihydropyridines, nondihydropyridines), nitrates (short- and long-acting)
  • Dosage Forms: Capsule, injection, patch, tablet
  • Routes of Administration: Injectable (intramuscular, intravenous), oral (controlled release, immediate release), sublingual (spray, tablet), transdermal (reservoir, single layer)
  • Distribution Channels: Hospital pharmacies, online pharmacies (B2B, B2C), retail pharmacies
  • End Users: Private and public clinics, caregiver- and self-administered homecare, private and public hospitals
  • Geographies: Americas (including US, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (spanning 20+ countries), Asia-Pacific (China, India, Japan, Australia, and others)
  • Leading Companies: Novartis AG, Pfizer Inc., Sanofi S.A., Bayer AG, AstraZeneca PLC, GlaxoSmithKline plc, Merck & Co. Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Viatris Inc.

Key Takeaways: Strategic Insights into the Angina Pectoris Drugs Market

  • Therapeutic evolution is evident with increased traction for combination regimens, precision therapy, and patient-centric modifications tailored per clinical guidelines.
  • Digital health integration and real-world evidence are reshaping monitoring and adherence, enabling more individualized care pathways across physical and virtual settings.
  • Regulatory frameworks are favoring agile development and approval cycles for drugs demonstrating robust safety and real-world effectiveness, increasing market entry velocity for new agents.
  • Supply chain re-calibrations are prompting manufacturers to evaluate sourcing strategies, explore onshoring, and invest in modular manufacturing platforms for resilience.
  • Regional trends highlight differentiated adoption: Americas lead in advanced drug uptake, EMEA markets focus on reimbursement optimization, and Asia-Pacific jurisdictions accelerate through local production and expanding hospital infrastructure.
  • Competitive strategies hinge on R&D investment, lifecycle management, targeted licensing, and digital partnership formations, supporting portfolio expansion and differentiation.

Tariff Impact: Effects of U.S. Trade Policy on Angina Drug Supply Chains

Recent U.S. tariff measures on pharmaceutical active ingredient imports have intensified cost pressures along the angina therapeutics supply chain. Companies are responding by revising sourcing and production strategies, with shifts towards onshoring or nearshoring to buffer against procurement volatility. Adjustments in contract negotiations and regulatory processes are further shaping the landscape, as site approvals and validation requirements become more complex. These changes necessitate ongoing scenario planning to maintain patient access while safeguarding operational margins.

Methodology & Data Sources

This report synthesizes findings from extensive primary interviews with clinical, procurement, and regulatory leaders, alongside analysis of peer-reviewed publications, market intelligence platforms, and corporate disclosures. Data consistency was ensured through triangulation and validation by relevant experts, while protecting data integrity and confidentiality at all stages.

Why This Report Matters: Actionable Strategic Value

  • Enables evidence-based decision-making for investment in supply chain resilience and R&D, by clarifying the business impacts of regulatory and market shifts.
  • Identifies actionable commercial pathways aligned with evolving patient and provider expectations, particularly in high-growth therapeutic and geographic segments.
  • Facilitates risk-managed market participation through comprehensive visibility into competitor strategies, emerging technologies, and critical policy developments.

Conclusion

Senior leaders navigating the angina pectoris drugs market face a complex landscape of evolving clinical, technological, and policy dynamics. Informed strategy and operational agility are key to capturing sustainable growth as the sector advances toward more patient-focused, digitally supported outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging role of gene therapy approaches in refractory angina management strategies
5.2. Adoption of long-acting nitrate delivery systems to improve patient adherence in angina
5.3. Integration of wearable cardiac monitoring technologies to personalize angina treatment protocols
5.4. Growing investment in novel sodium channel inhibitors for microvascular angina symptom control
5.5. Impact of telehealth-driven remote ischemia monitoring on angina pectoris patient outcomes
5.6. Rising demand for bioresorbable stent designs in managing chronic stable angina symptoms
5.7. Clinical trial focus on metabolic modulators to enhance myocardial efficiency in angina patients
5.8. Expansion of fixed-dose combination therapies targeting multi-pathway angina pathophysiology
5.9. Shift towards precision medicine using genetic biomarkers to stratify angina pectoris treatment
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Angina Pectoris Drugs Market, by Drug Class
8.1. Introduction
8.2. Ace Inhibitors
8.2.1. Enalapril
8.2.2. Lisinopril
8.3. Antiplatelet Agents
8.3.1. Aspirin
8.3.2. P2Y12 Inhibitors
8.4. Beta Blockers
8.4.1. Nonselective
8.4.2. Selective
8.5. Calcium Channel Blockers
8.5.1. Dihydropyridines
8.5.2. Nondihydropyridines
8.6. Nitrates
8.6.1. Long Acting
8.6.2. Short Acting
9. Angina Pectoris Drugs Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.3. Injection
9.4. Patch
9.5. Tablet
10. Angina Pectoris Drugs Market, by Route Of Administration
10.1. Introduction
10.2. Injectable
10.2.1. Intramuscular
10.2.2. Intravenous
10.3. Oral
10.3.1. Controlled Release
10.3.2. Immediate Release
10.4. Sublingual
10.4.1. Spray
10.4.2. Tablet
10.5. Transdermal
10.5.1. Reservoir
10.5.2. Single Layer
11. Angina Pectoris Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. Business To Business
11.3.2. Business To Consumer
11.4. Retail Pharmacies
12. Angina Pectoris Drugs Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. Private Clinics
12.2.2. Public Clinics
12.3. Homecare
12.3.1. Caregiver Administered
12.3.2. Self Administered
12.4. Hospitals
12.4.1. Private Hospitals
12.4.2. Public Hospitals
13. Americas Angina Pectoris Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Angina Pectoris Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Angina Pectoris Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novartis AG
16.3.2. Pfizer Inc.
16.3.3. Sanofi S.A.
16.3.4. Bayer AG
16.3.5. AstraZeneca PLC
16.3.6. GlaxoSmithKline plc
16.3.7. Merck & Co., Inc.
16.3.8. Johnson & Johnson
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANGINA PECTORIS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANGINA PECTORIS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANGINA PECTORIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANGINA PECTORIS DRUGS MARKET: RESEARCHAI
FIGURE 26. ANGINA PECTORIS DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. ANGINA PECTORIS DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. ANGINA PECTORIS DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANGINA PECTORIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ENALAPRIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ENALAPRIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LISINOPRIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LISINOPRIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ASPIRIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY P2Y12 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY P2Y12 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONSELECTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONSELECTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELECTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELECTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DIHYDROPYRIDINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DIHYDROPYRIDINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONDIHYDROPYRIDINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONDIHYDROPYRIDINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LONG ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LONG ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SHORT ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SHORT ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RESERVOIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SINGLE LAYER, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO BUSINESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO BUSINESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAREGIVER ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAREGIVER ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 211. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 212. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 213. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 214. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 215. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2024 (USD MILLION)
TABLE 216. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2025-2030 (USD MILLION)
TABLE 217. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2024 (USD MILLION)
TABLE 218. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2025-2030 (USD MILLION)
TABLE 219. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2024 (USD MILLION)
TABLE 220. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2025-2030 (USD MILLION)
TABLE 221. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2024 (USD MILLION)
TABLE 222. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2025-2030 (USD MILLION)
TABLE 223. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 224. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 225. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 228. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 229. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 230. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 231. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2024 (USD MILLION)
TABLE 232. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2025-2030 (USD MILLION)
TABLE 233. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 234. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 235. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 244. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 245. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 250. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 251. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2024 (USD MILLION)
TABLE 252. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2025-2030 (USD MILLION)
TABLE 253. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2025-2030 (USD MILLION)
TABLE 255. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2024 (USD MILLION)
TABLE 258. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2025-2030 (USD MILLION)
TABLE 259. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 260. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 261. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 264. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 265. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 266. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 267. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2024 (USD MILLION)
TABLE 268. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2025-2030 (USD MILLION)
TABLE 269. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 270. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 271. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 274. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 275. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 278. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 279. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 280. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 281. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 282. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 332. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 333. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 334. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 335. A

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Angina Pectoris Drugs market report include:
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Bayer AG
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.27 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.65 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Angina Pectoris Drugs - Global Strategic Business Report - Product Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Angina Pectoris Drugs Market Report 2025 - Product Image

Angina Pectoris Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Angina Pectoris Drugs Market Size, Share & Trends Analysis Report By Type (Stable Angina, Unstable Angina), By Drug Class (Beta Blockers, Anticoagulants), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Angina Pectoris Drugs Market Size, Share & Trends Analysis Report By Type (Stable Angina, Unstable Angina), By Drug Class (Beta Blockers, Anticoagulants), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Beta Blockers Market Report 2025 - Product Image

Beta Blockers Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Acute Coronary Syndrome Therapeutics Market by Drug Class (Anticoagulants, Antiplatelet Agents, Beta Blockers), Indication (NSTEMI, STEMI, Unstable Angina), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Acute Coronary Syndrome Therapeutics Market by Drug Class (Anticoagulants, Antiplatelet Agents, Beta Blockers), Indication (NSTEMI, STEMI, Unstable Angina), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From

About the Angina Pectoris Treatment Market

The Angina Pectoris Treatment market within the context of Cardiovascular Drugs is a highly competitive market, with a wide range of products available. These products are used to treat angina pectoris, a type of chest pain caused by reduced blood flow to the heart. Treatment options include lifestyle changes, medications, and surgical procedures. Medications used to treat angina pectoris include nitrates, beta-blockers, calcium channel blockers, and antiplatelet agents. These medications are used to reduce the frequency and severity of angina attacks, as well as to reduce the risk of heart attack and stroke. The Angina Pectoris Treatment market is driven by the increasing prevalence of cardiovascular diseases, the growing elderly population, and the increasing awareness of the importance of preventive healthcare. Some of the major companies in the Angina Pectoris Treatment market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.